MedAlliance’s SELUTION SLR drug eluting balloon (DEB) receives FDA investigational device exemption (IDE) approval – making it the first limus DEB to be available to US patients
- Monday, May 30, 2022, 7:11
- PR Newswire
- Add a comment
GENEVA, May 30, 2022 /PRNewswire/ — The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES). SELUTION SLR was also the first DEB (Drug Eluting Balloon) granted “breakthrough…
About the Author
admin has written 20655 stories on this site.